Skip to main content
Caplight Logo









Curavit

Curavit

Private
Scarsdale, New YorkHealthcare & Life Scienceshttps://curavit.io/

Last Round

Series A

Nov 14, 2022

Total Funding Raised

$8M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Curavit is a life sciences company that provides a virtual contract research organization (VCRO) for designing and executing decentralized clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotechnology, Patient Engagement, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

decentralized clinical trialsDCTvirtual contract research organizationVCROremote patient monitoringclinical trial managementreal-world evidenceRWEpatient recruitmentdigital health toolseClinical platformclinical research techdigital therapeuticsDTxvirtual clinical site

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Curavit Comparables

Compare Curavit with similar companies based on industry and business-model similarity.

Curavit comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lightship
87%
Curebase
85%
ObvioHealth
84%

Curavit Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 14, 2022

Key People

Founding team and executive leadership

Joel Morse

CEO & Co-Founder

Founding Team

Todd Morse

Chief Technology Officer

Executive Team

Curavit Investors

Notable investors and investment history

Curavit investors
InvestorRounds
Osage Venture PartnersSeries A
Royal Street VenturesSeries A
Narrow Gauge VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 27, 2026

    Grew 113% QoQ, from 23 to 49 employees.

  • Aug 21, 2026

    Monthly visitors increased 61% MoM.

Recent news

Latest coverage and updates

  • invests_into_assetsAug 23, 2026

    Curavit invests into assets: clinical research organization (CRO) assets in Europe.

  • expands_offices_toAug 18, 2026

    Curavit expanded offices to Europe on Aug 18th '26.

Curavit Filings

Explore SEC and related filing metadata, where available.

Curavit filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Curavit's valuation, stock price, and market status.

Is Curavit a public or private company?

Curavit is a private company.

What is the current stock price of Curavit?

Curavit is a private company with no public stock price. No recent secondary market data is available.

How much is Curavit worth (valuation)?

Valuation information for Curavit is not publicly available.

Can I buy Curavit stock?

Curavit shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Curavit's last funding round?

Curavit's most recent funding round was Series A on November 14, 2022.

Who are the main investors in Curavit?

Key investors in Curavit include Osage Venture Partners.

Will Curavit IPO soon?

No public IPO plans have been announced for Curavit.

How can I track Curavit secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curavit's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersScarsdale, New York
Employee Range42
Year Founded2020
Last FundingNov 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?